Wednesday, November 19, 2025
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study

Money Compass by Money Compass
October 29, 2025
in PR Newswire
0
Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

– New research confirms Jungbunzlauer’s TCC TB supports efficient, high-quality tablet manufacturing across challenging pharmaceutical and nutraceutical applications –

BASEL, Switzerland, Oct. 29, 2025 /PRNewswire/ — Jungbunzlauer, a global leader in high-quality, sustainable ingredients, and Professor Karl Wagner from the University of Bonn, announce the results of new research confirming Jungbunzlauer’s tricalcium citrate (TCC TB) sets a new standard for direct compression in pharmaceutical and nutraceutical tablet manufacturing.

Related posts

Industry First: OMOWAY Breaks New Ground in Smart Electric Motorcycle with Car-Grade Wind Tunnel Testing

Industry First: OMOWAY Breaks New Ground in Smart Electric Motorcycle with Car-Grade Wind Tunnel Testing

November 19, 2025
Philippines’ top fintech GCash unlocks Google Pay for millions of users

Philippines’ top fintech GCash unlocks Google Pay for millions of users

November 19, 2025
Young woman swallowing a small pill
Young woman swallowing a small pill

“This collaboration with Professor Wagner and his workgroup from the Department of Pharmaceutical Technology and Biopharmaceutics at the University of Bonn underscores our commitment to rigorous science, innovation and product excellence,” said Markus Gerhart, Senior Director Category Lead Minerals & Solutions at Jungbunzlauer. “Through validated research, we’re proud to demonstrate that our TCC TB delivers reliable performance in direct compression, helping our customers achieve efficiency, quality, and confidence.”

Direct compression is increasingly favoured for its efficiency and suitability for sensitive ingredients, but it demands excipients with exceptional flow and compactibility. The study results confirm Jungbunzlauer’s TCC TB delivers excellent flowability, robust tablet strength at low compression force, and rapid disintegration, even for challenging formulations such as minitablets, moisture-sensitive APIs, and botanical actives.

Produced by complete neutralisation of citric acid with a high purity calcium source, TCC TB is certified vegan, allergen- and GMO-free, and meets USP, FCC, and EU standards.

The new findings will be presented at CPHI Global, Messe Frankfurt (Hall 8, Booth Q55) from 28–30 October 2025. Attendees are invited to discuss the data with Jungbunzlauer and explore how TCC TB can naturally support your next formulation challenge. 

About Jungbunzlauer

Jungbunzlauer is a leading producer of high-quality, sustainable ingredients from natural sources, serving industries from food and beverage, to nutrition, health, home and personal care, among others. Leading the way in developing naturally better ingredients that enhance everyday life, we are a trusted partner offering a diverse portfolio of texturants, acidulants, sweeteners, minerals, and tailored solutions to meet our customers’ evolving needs.

Headquartered in Basel, Switzerland, with state-of-the-art facilities including large-scale fermentation operations across Europe and North America, we proudly serve more than 130 countries worldwide. Founded more than 150 years ago, Jungbunzlauer has grown into a CHF 1.3 billion company, driven by nearly 1,400 dedicated colleagues committed to a healthier, more sustainable future. Learn more at http://www.jungbunzlauer.com. 

​ 

Previous Post

I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform

Next Post

“Technology Should Serve Citizens” as World Cities Day in Chongqing Spotlights Global Urban Future

Next Post
“Technology Should Serve Citizens” as World Cities Day in Chongqing Spotlights Global Urban Future

"Technology Should Serve Citizens" as World Cities Day in Chongqing Spotlights Global Urban Future

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • Industry First: OMOWAY Breaks New Ground in Smart Electric Motorcycle with Car-Grade Wind Tunnel Testing
  • Philippines’ top fintech GCash unlocks Google Pay for millions of users
  • Philippines’ top fintech GCash unlocks Google Pay for millions of users

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved